Skip to content

Effect of Deep Analgosedation vs. Endotracheal Intubation General Anesthesia on on Perioperative Sedation Related Adverse Events in Elderly ERCP Patients

Effect of Deep Analgosedation vs. Endotracheal Intubation General Anesthesia on Perioperative Respiratory Adverse Events in Elderly ERCP Patients: An Open-Label Randomized Controlled Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07017283
Enrollment
170
Registered
2025-06-12
Start date
2025-11-10
Completion date
2026-02-28
Last updated
2025-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Biliary and Pancreatic Diseases, Endoscopic Retrograde Cholangiopancreatography (ERCP)

Brief summary

This study aims to investigate the impact of deep analgosedation versus endotracheal intubation general anesthesia on perioperative sedation related adverse events in elderly ERCP patients.

Detailed description

This study aims to investigate the impact of deep analgosedation versus endotracheal intubation general anesthesia on perioperative sedation related adverse events in elderly ERCP patients.

Interventions

DEVICETracheal intubation general anesthesia

Endotracheal intubation with general anesthesia was administered to the patient during the ERCP procedure.

DEVICENasopharyngeal airway ventilation

Nasopharyngeal airway-assisted deep sedation was employed for the patient during the ERCP procedure.

Sponsors

Gang Chen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

: 1. Aged 60 and above; 2. ASA physical status≤III; 3. Patients who scheduled for elective therapeutic ERCP (ERCP complexity grading system; 4. Willing to provide informed consent (or by legal guardian/witness if applicable).

Exclusion criteria

: 1: Altered gastrointestinal anatomy, delayed gastric emptying, or gastric outlet obstruction; 2.Coagulopathy or epistaxis tendency; 3.Cardiac diseases (e.g., coronary artery disease, heart failure, arrhythmias); 4.Pulmonary diseases (e.g., asthma, COPD); 5.Prior hypersensitivity to anesthetic agents; 6.Active upper respiratory infection; 7.Severe liver and kidney diseases; 8.Difficult airway: Preoperative anesthesiologist assessment of difficult airway; 9.Psychiatric disorders, cognitive impairment, critical illness, or pregnancy.

Design outcomes

Primary

MeasureTime frame
Perioperative sedation related adverse eventsPerioperative period

Secondary

MeasureTime frameDescription
Nasopharyngeal airway requires face mask ventilation or switching to tracheal intubationPerioperative
Second intubation after the tracheal intubation is removedPerioperative
Tachycardia (>100 beats/minute) or bradycardia (<50 beats/minute)Perioperative
Rating of reflux degreeperioperative
QoR-15 score on POD1Postoperative day 1
recovery room timePerioperative period
respiratory failure/ARDS incidencePerioperative
Postoperative cognitive function assessment (MoCA)PerioperativeThe Montreal Cognitive Assessment (MoCA) has a total score of 30 points, with a score of ≥26 considered normal
patient/endoscopist satisfactionPerioperativePatient/endoscopist satisfaction with sedation type was assessed using a 10-point visual analog scale (VAS), where 1 represented the worst possible experience and 10 indicated the optimal experience
hospital stay durationPerioperative
Incidence of postoperative nausea and vomitingpostoperative day 1

Countries

China

Contacts

Primary ContactXiaocui Lv
3412008@zju.edu.cn+8613567109477
Backup ContactGang Chen
chengang120@zju.edu.cn

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 28, 2026